MTL Cannabis Corp. (CSE: MTLC) announced its Q1 2023 financial outcomes on Monday through its subsidiary, Montréal Cannabis Médical Inc.

MTL Cannabis CEO Michael Perron expressed confidence in the company's growth trajectory, driven by a robust business model and customer satisfaction.

"Our team has done an outstanding job to help drive significant growth in both revenues and cash flows from operations over the last year. The results affirm that we have built …

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.